List of Studies ( Metabolite:Ala-Ser)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
---|---|---|---|---|---|---|---|
ST003790 | AN006230 | Fecal metabolomics of B16-OVA tumor-bearing mice fed chow or low and high fiber purified diets and treated with isotype control or anti-PD-1 antibody | Feces | Mouse | Cancer | Princeton University | LC-MS |
ST003768 | AN006185 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Leaf | Grass | Hunan Agricultural University | LC-MS | |
ST003768 | AN006185 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Roots | Grass | Hunan Agricultural University | LC-MS | |
ST003565 | AN005858 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST003521 | AN005783 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | LC-MS |
ST003179 | AN005222 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST003160 | AN005184 | New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
ST003036 | AN004978 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
ST003024 | AN004959 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 | Bacterial cells | Pseudomonas aeruginosa | Monash Institute of Pharmaceutical Sciences | LC-MS | |
ST002977 | AN004888 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | LC-MS | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | LC-MS | |
ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
ST002698 | AN004372 | Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites | Infected Red Blood Cells | Plasmodium berghei | Malaria | Peter Doherty Institute for Infection and Immunity | LC-MS |
ST002438 | AN003975 | Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice | Lung | Mouse | Asthma | University of California, Davis | LC-MS |
ST002407 | AN003924 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract | Intestine | Human | University of California, Davis | LC-MS | |
ST002263 | AN003697 | Intermittent fasting induces rapid hepatocyte proliferation to maintain the hepatostat | Liver | Mouse | Stanford University | LC-MS | |
ST002108 | AN003449 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST002107 | AN003446 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST002107 | AN003447 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST002106 | AN003445 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST002104 | AN003439 | Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations | Cultured cells | Human | Cancer | Future Industries Institute | LC-MS |
ST002010 | AN003276 | Chemoresistant Ovarian Cancer Global Metabolomics | Cultured cells | Human | Cancer | University of South Australia | LC-MS |
ST001888 | AN003057 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
ST001794 | AN002912 | Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples | Jejunum | Human | University of California, Davis | LC-MS | |
ST001745 | AN002838 | Metabolomic profiling of the rat hippocampus across developmental ages and after learning | Brain | Rat | New York University | LC-MS | |
ST001658 | AN002706 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Yeast | Cancer | Johns Hopkins University | LC-MS |
ST001658 | AN002708 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Yeast | Cancer | Johns Hopkins University | LC-MS |
ST001637 | AN002675 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
ST001547 | AN002577 | β-Adrenergic regulation of metabolism in macrophages | Macrophages | Human | Monash University | LC-MS | |
ST001324 | AN002202 | Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress | Hepatopancreas | Pacific Abalone | Institute of Oceanology, Chinese Academy of Sciences | LC-MS | |
ST001304 | AN002173 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | LC-MS |
ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
ST000546 | AN000833 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |